HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency.

AbstractCONTEXT:
Isolated 17,20 lyase deficiency is commonly defined by apparently normal 17α-hydroxylase activity but severely reduced 17,20 lyase activity of the bifunctional enzyme cytochrome P450 (CYP) enzyme 17A1 (CYP17A1), resulting in sex steroid deficiency but normal glucocorticoid and mineralocorticoid reserve. Cytochrome b5 (CYB5A) is thought to selectively enhance 17,20 lyase activity by facilitating the allosteric interaction of CYP17A1 with its electron donor P450 oxidoreductase (POR).
OBJECTIVE:
We investigated a large consanguineous family including three siblings with 46,XY disorder of sex development (DSD) presenting with isolated 17,20 lyase deficiency.
DESIGN:
We investigated the clinical and biochemical phenotype, conducted genetic analyses, and functionally characterized the identified CYB5A mutation in cell-based CYP17A1 coexpression assays.
RESULTS:
All three siblings presented with 46,XY DSD, sex steroid deficiency, normal mineralocorticoids and glucocorticoids, and a urine steroid metabolome suggestive of isolated 17,20 lyase deficiency. CYP17A1 and POR sequences were normal, but we detected a homozygous CYB5A missense mutation (g.28,400A→T; p.H44L). Functional in vitro analysis revealed normal CYP17A1 17α-hydroxylase activity but severely impaired 17,20 lyase activity. In silico analysis suggested the disruption of CYB5A heme binding by p.H44L.
CONCLUSION:
We have identified the first human CYB5A missense mutation as the cause of isolated 17,20 lyase deficiency in three individuals with 46,XY DSD. Detailed review of previously reported cases with apparently isolated 17,20 lyase deficiency due to mutant CYP17A1 and POR reveals impaired 17α-hydroxylase activity as assessed by steroid metabolome analysis and short cosyntropin testing. This suggests that truly isolated 17,20 lyase deficiency is observed only in individuals with inactivating CYB5A mutations.
AuthorsJan Idkowiak, Tabitha Randell, Vivek Dhir, Pushpa Patel, Cedric H L Shackleton, Norman F Taylor, Nils Krone, Wiebke Arlt
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 97 Issue 3 Pg. E465-75 (Mar 2012) ISSN: 1945-7197 [Electronic] United States
PMID22170710 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytochromes b5
  • CYP17A1 protein, human
  • Steroid 17-alpha-Hydroxylase
Topics
  • Adolescent
  • Adrenal Hyperplasia, Congenital (enzymology, genetics)
  • Child
  • Child, Preschool
  • Cytochromes b5 (genetics, metabolism)
  • Disorder of Sex Development, 46,XY (enzymology, genetics)
  • Humans
  • Infant
  • Infant, Newborn
  • Mutation, Missense
  • Steroid 17-alpha-Hydroxylase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: